Who
Christine E. Hamilton
Director
Company insider
Files Form 4 as: Director, Titan Machinery; Director and 10% owner, SAB Biotherapeutics; Director, Hf Financial.
In numbers
- Trades disclosed
- 47
- Buys
- 2
- Sells
- 0
- Bought
- $8,100
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 3 Jul 2006
- Last trade
- 8 Jun 2026
- Last filed
- 9 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Jun 2026filed 9 Jun 2026 | TITN Titan MachineryRetail — Specialty | SEC FORM 4 Code A | —3,353 at $0.00 | filing |
| 8 Jun 2026filed 9 Jun 2026 | TITN Titan MachineryRetail — Specialty | SEC FORM 4 Code A | —3,353 at $0.00 | filing |
| 2 Jun 2025filed 3 Jun 2025 | TITN Titan MachineryRetail — Specialty | SEC FORM 4 Code A | —4,322 at $0.00 | filing |
| 15 Jul 2024filed 17 Jul 2024 | SABS SAB Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 15 Jul 2024filed 17 Jul 2024 | SABS SAB Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,815 at $0.00 | filing |
| 15 Jul 2024filed 17 Jul 2024 | SABS SAB Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,447 at $0.00 | filing |
| 15 Jul 2024filed 17 Jul 2024 | SABS SAB Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,202 at $0.00 | filing |
| 15 Jul 2024filed 17 Jul 2024 | SABS SAB Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,326 at $0.00 | filing |
| 3 Jun 2024filed 5 Jun 2024 | TITN Titan MachineryRetail — Specialty | SEC FORM 4 Code A | —4,396 at $0.00 | filing |
| 5 Jun 2023filed 6 Jun 2023 | TITN Titan MachineryRetail — Specialty | SEC FORM 4 Code A | —2,989 at $0.00 | filing |
| 7 Dec 2022filed 9 Dec 2022 | SABS SAB Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —82,987 | filing |
| 7 Dec 2022filed 9 Dec 2022 | SABS SAB BiotherapeuticsBiotechnology | SEC FORM 4 Code A | $100K82,987 at $1.21 | filing |
| 13 Sep 2022filed 14 Sep 2022 | SABS SAB BiotherapeuticsBiotechnology | SEC FORM 4 Bought | $7,30010,000 at $0.73 | filing |
| 7 Jun 2022filed 10 Feb 2023 | SABS SAB BiotherapeuticsBiotechnology | SEC FORM 4 Code G | —2,000,000 | filing |
| 6 Jun 2022filed 7 Jun 2022 | TITN Titan MachineryRetail — Specialty | SEC FORM 4 Code A | —2,889 at $0.00 | filing |
| 22 Oct 2021filed 26 Oct 2021 | SABS SAB Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,039,938 | filing |
| 22 Oct 2021filed 26 Oct 2021 | SABS SAB Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,632 | filing |
| 22 Oct 2021filed 26 Oct 2021 | SABS SAB Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —34,896 | filing |
| 22 Oct 2021filed 26 Oct 2021 | SABS SAB Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,632 | filing |
| 22 Oct 2021filed 26 Oct 2021 | SABS SAB Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,632 | filing |
News
No headline names them, or the companies they trade most, lately.